We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$360B
AUM Growth
-$5.05B
Cap. Flow
-$2.61B
Cap. Flow %
-0.72%
Top 10 Hldgs %
13.81%
Holding
6,930
New
170
Increased
3,227
Reduced
2,806
Closed
155

Sector Composition

Rank Sector Weight
1 Technology 11.4%
2 Financials 10.07%
3 Consumer Discretionary 8.39%
4 Healthcare 7.69%
5 Communication Services 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBND icon
5526
Vident US Bond Strategy ETF
VBND
$523M
$115K ﹤0.01%
2,398
BBGI icon
5527
Beasley Broadcasting Group
BBGI
$37.8M
$114K ﹤0.01%
504
+25
+5% +$5.87K
ROM icon
5528
ProShares Ultra Technology
ROM
$1.12B
$113K ﹤0.01%
9,792
-65,472
-87% -$800K
BZM
5529
DELISTED
BlackRock Maryland Municipal Bond Trust
BZM
$113K ﹤0.01%
8,473
+2,994
+55% +$40.1K
ARLZ
5530
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$113K ﹤0.01%
74,818
+13,010
+21% +$22.7K
IVLU icon
5531
iShares MSCI Intl Value Factor ETF
IVLU
$4.42B
$112K ﹤0.01%
4,263
-572
-12% -$15.3K
UGL icon
5532
ProShares Ultra Gold
UGL
$650M
$112K ﹤0.01%
10,808
-60
-0.6% -$630
RJI
5533
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
$112K ﹤0.01%
20,349
-15,516
-43% -$85.1K
ERN
5534
DELISTED
Erin Energy Corp
ERN
$112K ﹤0.01%
30,757
+1,294
+4% +$4.36K
UHN
5535
DELISTED
United States Diesel-Heating Oil Fund, LP
UHN
$112K ﹤0.01%
5,854
-10,947
-65% -$205K
AST
5536
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$112K ﹤0.01%
77,367
+417
+0.5% +$871
CGG
5537
DELISTED
CGG
CGG
$112K ﹤0.01%
48,809
+12,159
+33% +$51.5K
ALDX icon
5538
Aldeyra Therapeutics
ALDX
$92.9M
$111K ﹤0.01%
14,796
+4,686
+46% +$35.6K
ESBK
5539
DELISTED
Elmira Savings Bank Elmira NY
ESBK
$111K ﹤0.01%
5,711
-4,185
-42% -$81.9K
KIQ
5540
DELISTED
Kelso Technologies Inc.
KIQ
$110K ﹤0.01%
189,800
+6,000
+3% +$3.69K
NJV
5541
DELISTED
Nuveen New Jersey Municipal Value Fund Common shares of beneficial interest
NJV
$110K ﹤0.01%
8,235
-918
-10% -$12.6K
SDOW icon
5542
ProShares UltraPro Short Dow 30
SDOW
$162M
$109K ﹤0.01%
87
+69
+383% +$80.1K
URE icon
5543
ProShares Ultra Real Estate
URE
$57.8M
$109K ﹤0.01%
1,896
+556
+41% +$32K
XOMA
5544
DELISTED
Xoma
XOMA
$109K ﹤0.01%
5,346
-44,560
-89% -$1.25M
SALM
5545
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$109K ﹤0.01%
30,409
+2,367
+8% +$10.2K
TYME
5546
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$109K ﹤0.01%
48,881
+23,835
+95% +$97.2K
UQM
5547
DELISTED
UQM Technologies, Inc.
UQM
$109K ﹤0.01%
84,835
+2,929
+4% +$3.97K
AEUA
5548
DELISTED
Anadarko Petroleum Corporation
AEUA
$109K ﹤0.01%
3,675
-835
-19% -$28.9K
ARTX
5549
DELISTED
Arotech Corporation
ARTX
$108K ﹤0.01%
35,211
-2,432
-6% -$8.3K
BBDO icon
5550
Banco Bradesco
BBDO
$36.4B
$107K ﹤0.01%
14,590
-414,049
-97% -$2.89M

Similar funds

Morgan Stanley's Q1 2018 Portfolio in Review

As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
  • Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
  • Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
  • Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
  • Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
  • Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
  • Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.